Lack of a detectable systemic humoral/cellular allogeneic response in human and nonhuman primate recipients of embryonic mesencephalic allografts for the therapy of Parkinson's disease.
Ansari
A A
AA
Department of Pathology, Emory University School of Medicine, Atlanta, Georgia.
Mayne
A
A
Freed
C R
CR
Breeze
R E
RE
Schneck
S A
SA
O'Brien
C F
CF
Kriek
E H
EH
Zhang
Y B
YB
Mazziotta
J C
JC
Hutchinson
M
M
D000818:Animals; D000917:Antibody Formation; D000920:Antibody-Dependent Cell Cytotoxicity; D016380:Brain Tissue Transplantation / Q000276:immunology*; D002460:Cell Line; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D016332:Fetal Tissue Transplantation / Q000276:immunology*; D005500:Follow-Up Studies; D006801:Humans; D007111:Immunity, Cellular; D007980:Levodopa / Q000627:therapeutic use; D008198:Lymph Nodes / Q000276:immunology; D008636:Mesencephalon / Q000637:transplantation*; D010300:Parkinson Disease / Q000503:physiopathology / Q000628:therapy*; D011241:Prednisone / Q000627:therapeutic use; D011323:Primates; D013154:Spleen / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D013997:Time Factors; D014184:Transplantation, Homologous
D007980:Levodopa; D016572:Cyclosporine; D011241:Prednisone